HEXO.TO - HEXO Corp.

HEXO Corp.

490 Boulevard Saint-Joseph
Suite 204
Gatineau, QC J8Y 3Y7
Canada
844-406-1852
http://www.hexocorp.com

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Sébastien G. St-Louis	Co-Founder, Pres, CEO & Director	358k	N/A	1984
Mr. Adam Miron	Co-Founder & Director	309.58k	N/A	1984
Mr. James McMillan	VP of Bus. Devel.	325.58k	N/A	1968
Dr. Terence Lake DVM	Vice-Pres of Corp. & Social Responsibility	256.15k	N/A	N/A
Mr. Stephen Harry-Donald Burwash	Chief Financial Officer	N/A	N/A	N/A

Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. HEXO Corp. is headquartered in Gatineau, Canada.

Corporate Governance

HEXO Corp.’s ISS Governance QualityScore as of October 4, 2019 is 9. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.